← Every applicant
Jubilant Cadista FDA Approvals
4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| METHENAMINE HIPPURATENew drugDec 1, 2023TABLET, ORAL |
| LOPERAMIDE HYDROCHLORIDENew drugJul 5, 2023CAPSULE, ORAL |
| DOXEPIN HYDROCHLORIDENew drugMar 14, 2022CAPSULE, ORAL |
| DROXIDOPANew drugFeb 18, 2021CAPSULE, ORAL |